Xconomy

NOVEMBER 1, 2018

In some ways, the biggest software acquisition of all time could be a yawner. IBM’s planned $34 billion deal to acquire open-source software maker Red Hat is a hefty price to pay to give its cloud computing business a shot in the arm.

IBM 100

IBM IBM Cloud Computing Google 100

Xconomy

MARCH 20, 2017

Japan’s Murata Manufacturing has acquired Arctic Sand Technologies of Burlington, MA, and plans to combine Arctic Sand’s low-power semiconductor technology with its San Diego-based subsidiary, Peregrine Semiconductor. The purchase price was $68 million, according to a Peregrine spokeswoman.

San Diego 63

San Diego Mobile Pricing Technology 63

Xconomy

JULY 7, 2016

Pernix Therapeutics is slashing its headcount by more than 20 percent as the specialty pharmaceutical company tries to move toward profitability after a streak of acquisitions. In 2014, Pernix, then based in The Woodlands, TX, acquired San Diego-based Somaxon Pharmaceuticals. Those acquisitions helped Pernix reach $175.8

Sales 40

Sales San Diego .Net Report 40

Xconomy

DECEMBER 9, 2019

The move is the first acquisition the company has announced since CEO Paul Hudson joined the Paris-headquartered company Sept. Sanofi agreed to pay $68 per outstanding share of Synthorx, a 172 percent premium over its Friday closing stock price of $25.03 Its stock shot to $67.71

Pricing 52

Pricing Design Acquisition Help 52

Xconomy

SEPTEMBER 7, 2016

San Diego-based Retrophin said that its drug, sparsentan, outperformed another drug sometimes used to manage a rare kidney disease, called focal segmental glomerulosclerosis (FSGS), in a Phase 2 clinical trial. He licensed the drug from San Diego-based Ligand Pharmaceuticals (NASDAQ: LGND ) in March 2012. to $30 apiece.

San Diego 40

San Diego Pricing Study Journal 40

Xconomy

JUNE 3, 2016

Thousands of others will head to San Francisco for BIO, which has a distinct international flavor. But billions of dollars in acquisitions will be left by the side of the road. Bad FDA news for Teva Pharmaceutical and AstraZeneca also threw outsized acquisitions into question. Teva nabbed deutetrabenazine in its $3.2

San Diego 62

San Diego Patents Acquisition News 62

Xconomy

OCTOBER 7, 2016

PRICE FIGHTS. With some caveats, ICER recommended lower prices. —San Diego: Biotech firm Sirenas reeled in a grant from the Bill and Melinda Gates Foundation to extract chemicals from marine organisms that might treat neglected diseases. In December we’ll gather in San Francisco to discuss the U.S.

Technical Review 77

Technical Review Study Layoffs San Diego 77

Xconomy

AUGUST 16, 2017

Private equity investors have more capital at their disposal than at any time in more than a decade, which could boost prices for companies seeking acquisitions. As of Aug. 1, private equity firms in North America and Europe had secured $212.6

Equity 69

Equity Pricing Acquisition Report 69

Xconomy

MAY 24, 2019

Patients, doctors, family members, and drug-price watchdogs continued to wait for the expected approval of Zolgensma , a Novartis (NYSE: NVS ) gene therapy for the rare inherited disease spinal muscular atrophy. Originally developed at a children’s hospital in Ohio , Zolgensma will be a litmus test for the nascent field.

Pricing 86

Pricing Marketing Develop Development 86

Xconomy

SEPTEMBER 20, 2019

Meanwhile, try to find someone in the federal government who isn’t involved in the drug-price debate. Health concerns about vaping continue to mount, and the feds could get involved.

Pricing 61

Pricing News Capital San Diego 61

Xconomy

AUGUST 30, 2016

Petco, the privately held pet supplies company based in San Diego, said today it led a $10 million Series A financing in Los Angeles-based Petnet, a three-year-old startup developing technology-enabled pet feeders and pet food delivery service. The deal also reflects Petco’s expanding interests in technology following the company’s $4.6-billion

San Diego 52

San Diego Los Angeles Mobile Equity 52

Xconomy

AUGUST 16, 2016

The industry can only go so far with growth through hyper-inflated pricing and mega-M&As. At some point pharma has to figure out how to make more drugs more efficiently, or face major dislocations like business-destroying price controls. The increasing need for new drugs is intense.

Product 40

Product Journal Venture Capital Demand 40

Xconomy

JULY 1, 2016

At the gathering, Biden took verbal shots at scofflaw cancer researchers and at drug prices, while the FDA said it would take a shot at restructuring the way it evaluates oncology products. Gilead Sciences has been a target of drug-price criticism for its hepatitis C treatments, but it dialed back the price of its new one.

Buzzfeed 59

Buzzfeed News Pricing IBM 59

Xconomy

JANUARY 4, 2019

Topics ranged from the worries over CRISPR genome editing and Wild West biohacking, to Nobel Prize-fueled drug approvals and the headaches around drug prices (even for drugs meant to cure headaches). You’ll find a few of our favorite stories in this review of some of the year’s best from across the Xconomy network.

Pricing 69

Pricing Email Networking Silver Lake 69

Xconomy

AUGUST 3, 2018

Millions of people might be on vacation as we hit the dog days, but drug makers and politicians aren’t taking a break from the gamesmanship over high drug prices. Pfizer’s chief executive, recently in Trump’s crosshairs. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

Pricing 49

Pricing Venture Capital San Diego Company 49

Xconomy

OCTOBER 3, 2018

Share prices for the two Silicon Valley companies spiked in after-hours trading following the announcement Wednesday that both their boards approved the all-stock deal.

Platform 93

Platform Software Review Web Pricing 93

Xconomy

JANUARY 26, 2018

The United States has a new Health and Human Services chief who is expected to weigh in on the country’s drug-pricing debate. Xconomy examined its owners’ justification for the price, and why a drug-value watchdog pushed back hard.

Pricing 49

Pricing News Services San Diego 49

Xconomy

SEPTEMBER 1, 2017

billion, the price Gilead Sciences is paying for Kite Pharma and its cancer-fighting cell therapy pipeline. The far-out idea of reprogramming a patient’s immune cells to fight cancer, known as CAR-T, entered the mainstream this week, and two numbers highlight the tale. The first is $11.9

Pricing 74

Pricing Ideas San Diego Study 74

Xconomy

OCTOBER 5, 2018

By year’s end San Diego’s Senomyx will be part of Firmenich, a privately held Swiss fragrance and flavor company. But since then its stock price has fallen significantly, dropping below $1 per share multiple times in the past two years, which nearly got the listing booted from the Nasdaq exchange. Through a U.S.

Pricing 81

Pricing Report Sales Company 81

Xconomy

APRIL 6, 2018

There were plenty of policy and drug-price headlines, Read more » Reprints | Share: The FDA didn’t smile upon a big submission of depression studies from Alkermes, while those fighting liver disease got a mixed slate of data as a big medical conference looms.

Study 55

Study Pricing Conference Marketing 55

Xconomy

APRIL 20, 2018

The price of drugs is certainly on a lot of minds these days, including the mind of President Trump, as he reportedly will make a. While pembrolizumab notched the headline-grabbing data, others are also working to develop options for various subsets of patients. Who will be able to afford all these options?

Pricing 52

Pricing News Report Develop 52

Xconomy

JULY 21, 2016

After a year in which Biogen’s share price has fallen by more than a third and one of its top drug prospects failed, Scangos, who has led the company since 2010, has announced plans to step down. Biogen has been very deliberate in its dealmaking, reluctant to make a big splash with a large acquisition. [ Updated, 9:20 a.m.

San Diego 40

San Diego Conference Pricing Acquisition 40

Xconomy

AUGUST 11, 2017

The FDA reported that generic drug approvals are set to hit a record ; the agency under Commissioner Scott Gottlieb has moved this summer to increase generic competition and lower the nation’s high drug prices. Meanwhile, drug-price hawks can sharpen their talons on a report this week from The New York Times and ProPublica.

Pricing 52

Pricing News Report Competition 52

Xconomy

JULY 29, 2016

But the company said this week that sales of Sovaldi and Harvoni, which share a common ingredient, sofosbuvir, have slowed with fewer patients starting on the drugs and prices undercut by fierce competition from AbbVie and Merck. But our minds jumped to politics. How about we start a pool? Shares closed Thursday at $9.60

Startup 40

Startup Study News Report 40

Xconomy

FEBRUARY 16, 2018

There was talk of tackling high drug prices in the budget document, but nothing to give Medicare direct negotiating power with drug companies or allow importation of cheaper drugs from other countries—ideas Trump has embraced on occasion.

Pricing 57

Pricing Ideas Artificial Inteligence San Diego 57

Xconomy

MARCH 12, 2018

The two companies had yet to even agree on a price in what was widely reported to represent the biggest tech deal in history. Singapore-based Broadcom had submitted bids ranging from. Read more » Reprints | Share:

Pricing 45

Pricing Report San Diego Company 45

Xconomy

JULY 18, 2016

In early trading Monday, Evoke’s (NASDAQ: EVOK ) stock price was down 72 percent to $3.02 Actavis is now known as Allergan (NYSE: AGN ), adopting the name following its acquisition of that company last year. per share as of 11:30 a.m. in New York. Reprints | Share: UNDERWRITERS AND PARTNERS.

Study 40

Study Sites News Research 40

Xconomy

AUGUST 2, 2019

Acquisitions made Pfizer what it is today: the world’s biggest drug maker measured by revenue. Blockbuster drugs such as Viagra and Lipitor, which came via acquisitions, are currently sold by Upjohn, Pfizer’s off-patent drug division. But as the company maps its future, CEO Albert Bourla is breaking some of that legacy apart.

Patents 18

Patents Acquisition Product Develop 18

Xconomy

AUGUST 30, 2019

You might be camping, barbecuing, or sleeping on Monday. It’s Labor Day, after all. But in Paris, this cardiologist will be in a conference center, walking an audience through a slide deck packed with Phase 3 data for a new cholesterol-lowering drug, inclisiran. Inclisiran’s owner, the Medicines Co.,

Slides 80

Slides Conference Venture Capital San Diego 80

Xconomy

JUNE 28, 2019

It was a busy week. If we had to choose a theme, it was all about getting together. Two huge drug companies, AbbVie and Allergan, said they’d be better as one. Two more huge drug companies, Celgene and Bristol-Myers Squibb, learned they would have to leave a big product behind if they want to merge.

Product 65

Product Company Companies San Diego 65

Xconomy

AUGUST 12, 2016

Celgene paid Acetylon $100 million in 2013 for an option to buy the company outright, but the deal recently expired without an acquisition, leaving Acetylon to chart a new course. . —Option-to-buy deals are by definition no guarantee, and an agreement between Boston-based Acetylon Pharmaceuticals and Celgene is the latest example.

Google 40

Google Technical Review News Research 40

Xconomy

OCTOBER 27, 2017

The White House and the FDA turned the spotlight on the nation’s opioid crisis. Blockbuster drugs from Alexion and Tesaro gained expanded approvals, but bad earnings news from Celgene and Biogen brought stocks down. Academics in the U.S. and China made progress with the gene editing technology CRISPR.

News 57

News Research Technology San Diego 57

SoCal Delicious

OCTOBER 8, 2012

Developments Blog. Prices are soaring in the beachfront communities tech types favor, and rents in these. Prices have gone up dramatically on this beachfront strip. Venices median home price in the first eight months of 2012 broke the $1 million barrier, rising to $1,012,000 from $899,000 in the first eight months of 2011.

Los Angeles 44

Los Angeles Software Review Technical Review Journal 44

SoCal Delicious

MAY 6, 2012

Charlie Capen is co-founder of HowToBeADad.com , an entertainment site and dad blog for “parents, soon-to-be parents and people who have no desire to procreate, whatsoever.” He previously led business development for Affiliate Fuel, leading to its acquisition by Experian in 2005. She just spoke at TED EX in San Diego.

Los Angeles 78

Los Angeles Entrepreneur Angel Fractional CTO 78